West Pharmaceutical Services (WST) Shares Outstanding (Weighted Average) (2009 - 2026)

West Pharmaceutical Services' Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $72.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) fell 0.69% year-over-year to $72.0 million; the TTM figure through Mar 2026 stood at $72.0 million (down 0.69% YoY), while the FY2025 annual figure was $72.3 million, down 0.96% from the prior year.
• Shares Outstanding (Weighted Average) came in at $72.0 million for Q1 2026 at West Pharmaceutical Services, roughly flat from $72.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $74.5 million in Q1 2023 to a low of $72.0 million in Q1 2026.
• A 5-year average of $73.5 million and a median of $73.5 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) advanced 0.68% in 2022 and decreased 2.02% in 2024, its largest moves.
• West Pharmaceutical Services' Shares Outstanding (Weighted Average) stood at $74.4 million in 2022, then slipped by 0.13% to $74.3 million in 2023, then declined by 1.75% to $73.0 million in 2024, then slipped by 0.96% to $72.3 million in 2025, then slipped by 0.41% to $72.0 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $72.0 million, $72.3 million, and $72.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison